CUBE vs DNTH
CubeSmart (CUBE) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the CUBE and DNTH stock pages for the full models.
Not investment advice.